KR20140054160A - 콜라겐 7 및 관련 방법들 - Google Patents

콜라겐 7 및 관련 방법들 Download PDF

Info

Publication number
KR20140054160A
KR20140054160A KR1020147005544A KR20147005544A KR20140054160A KR 20140054160 A KR20140054160 A KR 20140054160A KR 1020147005544 A KR1020147005544 A KR 1020147005544A KR 20147005544 A KR20147005544 A KR 20147005544A KR 20140054160 A KR20140054160 A KR 20140054160A
Authority
KR
South Korea
Prior art keywords
gly
pro
collagen
leu
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147005544A
Other languages
English (en)
Korean (ko)
Inventor
소우자 마크 데
말리니 비스와나탄
Original Assignee
로터스 티슈 리페어 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로터스 티슈 리페어 인코포레이티드 filed Critical 로터스 티슈 리페어 인코포레이티드
Publication of KR20140054160A publication Critical patent/KR20140054160A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/13Dipeptidases (3.4.13)
    • C12Y304/13009Xaa-Pro dipeptidase (3.4.13.9) i.e. prolidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1081Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/485Exopeptidases (3.4.11-3.4.19)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
KR1020147005544A 2011-08-03 2012-08-03 콜라겐 7 및 관련 방법들 Ceased KR20140054160A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161514796P 2011-08-03 2011-08-03
US61/514,796 2011-08-03
PCT/US2012/049553 WO2013020064A1 (en) 2011-08-03 2012-08-03 Collagen 7 and related methods

Publications (1)

Publication Number Publication Date
KR20140054160A true KR20140054160A (ko) 2014-05-08

Family

ID=47629706

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147005544A Ceased KR20140054160A (ko) 2011-08-03 2012-08-03 콜라겐 7 및 관련 방법들

Country Status (10)

Country Link
US (1) US9676837B2 (enExample)
EP (1) EP2753704A4 (enExample)
JP (2) JP2014524241A (enExample)
KR (1) KR20140054160A (enExample)
CN (2) CN108165593A (enExample)
AU (2) AU2012289916B2 (enExample)
BR (1) BR112014002546A2 (enExample)
CA (1) CA2843896A1 (enExample)
MX (1) MX351565B (enExample)
WO (1) WO2013020064A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160009738A (ko) * 2014-07-16 2016-01-27 주식회사 엘지생활건강 피부 주름 개선용 화장료 조성물
KR20180102647A (ko) * 2016-01-28 2018-09-17 노르딕 바이오사이언스 에이/에스 콜라겐 타입 vii 알파 1 분석

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523330A (ja) 2000-02-04 2003-08-05 チルドレンズ・ホスピタル・リサーチ・ファウンデイション アテローム性動脈硬化症および関連疾患のための脂質加水分解治療
ES2950358T3 (es) 2010-04-23 2023-10-09 Alexion Pharma Inc Enzima de la enfermedad de almacenamiento lisosomal
RU2550961C2 (ru) 2010-09-09 2015-05-20 Синаджева Биофарма Корп. Использование кислой лизосомной липазы для лечения дефицита кислой лизосомной липазы у больных
KR20140006037A (ko) 2011-02-15 2014-01-15 시나게바 바이오파르마, 코포레이션 리소좀의 산 리파제 결핍을 치료하는 방법들
US9040484B2 (en) * 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
WO2015117021A1 (en) 2014-01-31 2015-08-06 Factor Bioscience Inc. Methods and products for nucleic acid production and delivery
JP2017513833A (ja) * 2014-04-08 2017-06-01 ユニヴァーシティー オブ サザン カリフォルニア Vii型コラーゲンフィブロネクチンiii型様リピートを有するポリペプチド組成物ならびに創傷の閉鎖および治癒のための治療方法
EP3543339A1 (en) 2015-02-13 2019-09-25 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
JP6985282B2 (ja) * 2016-03-16 2021-12-22 フェニックス ティシュー リペア インコーポレイテッドPhoenix Tissue Repair, Inc. 7型コラーゲンの精製方法
CN109803977B (zh) 2016-08-17 2023-03-17 菲克特生物科学股份有限公司 核酸产品及其施用方法
US11384135B2 (en) * 2017-09-22 2022-07-12 Modern Meadow, Inc. Recombinant yeast strains
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
CN109022464A (zh) * 2018-07-02 2018-12-18 西安巨子生物基因技术股份有限公司 重组人源型胶原蛋白的羟基化方法
EP3946596A4 (en) * 2019-03-27 2022-12-21 Phoenix Tissue Repair, Inc. SYSTEMS AND METHODS OF PRODUCING COLLAGEN COMPOSITIONS 7
JP7777451B2 (ja) 2019-04-12 2025-11-28 ジェルター, インコーポレイテッド 組換えエラスチンおよびその産生
WO2021003462A1 (en) 2019-07-03 2021-01-07 Factor Bioscience Inc. Cationic lipids and uses thereof
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
AU2021211721A1 (en) 2020-01-24 2022-08-18 Geltor, Inc. Animal-free dietary collagen
KR20240004264A (ko) * 2021-03-04 2024-01-11 젤라텍, 인크. 배양된 동물 세포로부터의 콜라겐을 사용한 재료의 제조 방법
AU2022366945A1 (en) 2021-10-12 2024-05-23 Phoenix Tissue Repair, Inc. Collagen 7 protein replacement therapy
CN117143223B (zh) * 2022-08-23 2024-03-08 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法
CN116854807A (zh) * 2023-07-26 2023-10-10 浙江大学 一种重组人源ⅶ型胶原蛋白及其制备方法与应用
CN120137008B (zh) * 2025-03-18 2025-09-26 广东普言生物科技有限公司 一种重组Ⅶ型胶原蛋白Pro.C7及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
AU6181200A (en) * 1999-07-29 2001-02-19 Helix Research Institute Stomach cancer-associated gene
US7026463B2 (en) 1999-08-13 2006-04-11 Matthew Glenn Polynucleotides and polypeptides, materials incorporating them and methods for using them
AU1593001A (en) * 1999-11-12 2001-06-06 Fibrogen, Inc. Recombinant gelatin in vaccines
CN1552889A (zh) * 2003-12-18 2004-12-08 四川铭让生物科技有限公司 制备胶原蛋白和胶原多肽的方法及其用途
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
US9040484B2 (en) * 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160009738A (ko) * 2014-07-16 2016-01-27 주식회사 엘지생활건강 피부 주름 개선용 화장료 조성물
KR20180102647A (ko) * 2016-01-28 2018-09-17 노르딕 바이오사이언스 에이/에스 콜라겐 타입 vii 알파 1 분석

Also Published As

Publication number Publication date
AU2017254910A1 (en) 2017-11-23
US20150011733A1 (en) 2015-01-08
EP2753704A4 (en) 2015-07-08
MX351565B (es) 2017-10-19
CA2843896A1 (en) 2013-02-07
US9676837B2 (en) 2017-06-13
EP2753704A1 (en) 2014-07-16
JP2017209117A (ja) 2017-11-30
JP2014524241A (ja) 2014-09-22
CN103842517A (zh) 2014-06-04
AU2012289916B2 (en) 2017-08-03
MX2014001383A (es) 2014-08-26
WO2013020064A1 (en) 2013-02-07
CN108165593A (zh) 2018-06-15
AU2012289916A1 (en) 2014-02-20
BR112014002546A2 (pt) 2017-03-14

Similar Documents

Publication Publication Date Title
KR20140054160A (ko) 콜라겐 7 및 관련 방법들
EP3365452B1 (en) Expression in mammalian cells with gaussia luciferase signal peptide
CN108610398B (zh) 一段功能序列及在分泌蛋白表达中的应用
WO2006103258A1 (en) Method for improved isolation of recombinantly produced proteins
EP1127154A1 (en) Method for the production of fvii
CN104387473B (zh) 用于非酶切非色谱纯化方法原核表达融合蛋白Prx的类弹性蛋白多肽ELP
WO2020094005A1 (zh) 重组Martentoxin的制备、表征及应用
CN115176019B (zh) 能够在微藻类的叶绿体中产生胶原蛋白、弹性蛋白及其衍生物的肽、多肽或蛋白质的重组微藻类及其相关方法
US20180002401A1 (en) Collagen 7 and related methods
WO2019143193A9 (ko) 재조합 폴리펩타이드 생산용 n-말단 융합 파트너 및 이를 이용하여 재조합 폴리 펩타이드를 생산하는방법
CN113755459A (zh) 固氮酶蛋白变体
CN115551884A (zh) 能产生kttks肽、多肽或蛋白和它们的衍生物的重组微藻以及其相关方法和用途
CN118755746A (zh) 重组质粒、构建方法及μ-芋螺毒素肽的原核表达方法
CN113061598B (zh) 胰蛋白酶突变体、其制备方法及其应用
JPH03259084A (ja) トロンビン結合性物質の製造法
EP2633058B1 (en) Method for mass production of factor vii/viia
CN114703168B (zh) 一种肝素酶iii
CN101736008B (zh) 一种制备基因工程N-乙酰化胸腺素α1的方法
CN109293763B (zh) 水貂激活素b蛋白及其制备与应用
KR101367869B1 (ko) 라이신 태깅을 통한 펩티딜글리신 아미데이팅 모노옥시젼네이즈 효소 단백질의 고순도 정제방법
WO2025104126A1 (en) Tags for enhanced expression of recombinant proteins
CN114761418A (zh) Cho细胞衍生的蛋白分泌因子和包含它的表达载体
CN102851303A (zh) 一种类凝血酶基因及其应用
MXPA01009979A (en) Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
KR20050018231A (ko) 인간 유래 조직형 플라스미노겐 활성화 인자의 대량발현용 재조합 유전자 및 그 단백질의 재구성 방법

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140228

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170801

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180711

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180914

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20180711

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I